Consensus on diagnosis and management of Cushing's disease: a guideline update
M Fleseriu, R Auchus, I Bancos… - The lancet Diabetes & …, 2021 - thelancet.com
Cushing's disease requires accurate diagnosis, careful treatment selection, and long-term
management to optimise patient outcomes. The Pituitary Society convened a consensus …
management to optimise patient outcomes. The Pituitary Society convened a consensus …
Diagnosis and management of pituitary adenomas: a review
NA Tritos, KK Miller - Jama, 2023 - jamanetwork.com
Importance Pituitary adenomas are neoplasms of the pituitary adenohypophyseal cell
lineage and include functioning tumors, characterized by the secretion of pituitary hormones …
lineage and include functioning tumors, characterized by the secretion of pituitary hormones …
Current and future advances in surgical therapy for pituitary adenoma
DZ Khan, JG Hanrahan, SE Baldeweg… - Endocrine …, 2023 - academic.oup.com
The vital physiological role of the pituitary gland, alongside its proximity to critical
neurovascular structures, means that pituitary adenomas can cause significant morbidity or …
neurovascular structures, means that pituitary adenomas can cause significant morbidity or …
New types of localization methods for adrenocorticotropic hormone-dependent Cushing's syndrome
R Senanayake, D Gillett, J MacFarlane… - Best Practice & …, 2021 - Elsevier
The management of endogenous Cushing's syndrome (CS) typically involves two key
steps:(i) confirmation of autonomous hypercortisolism and (ii) localization of the cause to …
steps:(i) confirmation of autonomous hypercortisolism and (ii) localization of the cause to …
[HTML][HTML] Endoscopic surgery for pituitary tumors
WR Van Furth, F De Vries, DJ Lobatto… - Endocrinology and …, 2020 - endo.theclinics.com
Endoscopic Surgery for Pituitary Tumors - Endocrinology and Metabolism Clinics Skip to Main
Content Skip to Main Menu Advertisement Endocrinology and Metabolism Clinics Log in …
Content Skip to Main Menu Advertisement Endocrinology and Metabolism Clinics Log in …
[HTML][HTML] Neuro-ophthalmic evaluation and management of pituitary disease
MTM Wang, JA Meyer, HV Danesh-Meyer - Eye, 2024 - nature.com
Neuro-ophthalmic evaluation is a crucial component of the diagnostic and prognostic
assessment of pituitary disease and compressive chiasmopathy, and can inform the timing …
assessment of pituitary disease and compressive chiasmopathy, and can inform the timing …
[HTML][HTML] The clinical outcomes of imaging modalities for surgical management Cushing's disease–A systematic review and meta-analysis
CH Koh, DZ Khan, R Digpal… - Frontiers in …, 2023 - frontiersin.org
Introduction Cushing's disease presents major diagnostic and management challenges.
Although numerous preoperative and intraoperative imaging modalities have been …
Although numerous preoperative and intraoperative imaging modalities have been …
Pituitary incidentaloma
SM Constantinescu, D Maiter - La Presse Médicale, 2021 - Elsevier
Pituitary incidentalomas (PI) are lesions of the pituitary region discovered fortuitously by
imaging for reasons unrelated to pituitary disease. They range from small cysts to large …
imaging for reasons unrelated to pituitary disease. They range from small cysts to large …
[HTML][HTML] Pituitary tumor centers of excellence for Cushing's disease
Pituitary tumors are more frequent than commonly thought [1, 2]. Despite the significant
progress of pituitary sciences in the last years, some pituitary adenomas still present …
progress of pituitary sciences in the last years, some pituitary adenomas still present …
Growth hormone receptor antagonist pegvisomant and its role in the medical therapy of growth hormone excess
J MacFarlane, M Korbonits - … Practice & Research Clinical Endocrinology & …, 2024 - Elsevier
Pegvisomant is a growth-hormone (GH) receptor antagonist that prevents the formation of
the active heterotrimer of the dimerised GH receptor and the GH molecule necessary for …
the active heterotrimer of the dimerised GH receptor and the GH molecule necessary for …